The Eskitis Institute for Cell and Molecular Therapies at Griffith University in Brisbane, Australia is establishing a publicly accessible dedicated compound management repository. This facility, known as the Queensland Compound Library (QCL), will give Australian chemists the opportunity to screen their compounds against a wide range of biological targets, without loss of intellectual property (IP). Biologists who use of the facility, likewise, retain control of their IP. A key element of the QCL is the ability to store compounds format-free, allowing, therefore, the possibility to deliver samples in a wide range of formats as desired by the customers. The automation to support this process has been carefully chosen to ensure that it meets the rigorous demands of supporting a customer-focused facility. This presentation describes a unique approach to stimulating drug discovery that best suits Australian circumstances and the automation that is being used to accomplish this.